Search Results
Slidesets
Optimal Use of Integrase Inhibitors in Women- Sharon Walmsley, FRCPC, MD, MSC
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Eliminating Hepatitis C by 2030 - Enhancing prevention care and treatment among people who inject drugs- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
HEP DART 2017
Slidesets
Pharmacokinetic and virological efficacy of dolutegravir (50 mg BID) containing regimen in association with rifampin in HIV-infected patients using Dried Blood Spot: ANRS-12313 NAMSAL sub-study in Cameroon- Le
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Country Experiences: Western Europe / France
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
(Abstract) Enteric virome analysis of non-invasive samples from gorillas by next-generation sequencing and association with SIV infection | M. D’arc
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016
Slidesets
Abstract #2 Five-Year Trends in Characteristics and Care of Women Diagnosed with HIV during Pregnancy in England, 2018 to 2022 - Rebecca Sconza
Presented at:
15th International Workshop on Women & HIV 2025
Slidesets
Oral Abstract Presentation #2 | Sohaib Khan
Presented at:
European Meeting on HIV & Hepatitis 2024
Slidesets
New Treatment in HCV: Is there need for more therapies? - Jordan Feld, MD, MPH
Presented at:
International Hepatitis Cure & Eradication Meeting 2015